These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4799542)

  • 1. [Therapeutic effects on metabolism by lowering of blood viscosity (defibrase)].
    Köhler M; Martin M; Krüpe M
    Verh Dtsch Ges Inn Med; 1973; 79():1400-2. PubMed ID: 4799542
    [No Abstract]   [Full Text] [Related]  

  • 2. [Improvement of blood viscosity through Arvin].
    Ehrly AM; Breddin K
    Verh Dtsch Ges Inn Med; 1972; 78():620-4. PubMed ID: 4677224
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic defibrination with ancrod (author's transl)].
    Ehringer H; Dudczak R; Lechner K
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2298-304. PubMed ID: 4797013
    [No Abstract]   [Full Text] [Related]  

  • 4. [Improvement of flow properties of blood: a new principle for drug therapy of chronic peripheral arterial vascular disorders].
    Ehrly AM
    Vasa Suppl; 1973; 1():1-18. PubMed ID: 4517911
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood viscosity under defibrase and combined defibrase and streptokinase therapy].
    Völker D; Martin M
    Verh Dtsch Ges Inn Med; 1973; 79():1338-40. PubMed ID: 4799540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Improvement of flow properties of human blood by subcutaneous administration of arwin].
    Ehrly AM; Jung HJ
    Verh Dtsch Ges Inn Med; 1973; 79():1397-400. PubMed ID: 4799541
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic defibrination using snake venom (Arvin) in arterial circulation disorders].
    Ehringer H; Dudczak E; Lechner K; Widhalm F
    Verh Dtsch Ges Inn Med; 1972; 78():624-7. PubMed ID: 4677225
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic lowering of fibrinogen levels].
    Ernst E
    MMW Munch Med Wochenschr; 1983 May; 125(21):83-4. PubMed ID: 6410202
    [No Abstract]   [Full Text] [Related]  

  • 9. [New possibilities in the rheologic-therapeutic influencing of blood viscosity in angiologic diseases].
    Ehrly AM; Glatz A; Scheinpflug W
    Verh Dtsch Ges Inn Med; 1974; 80():1450-2. PubMed ID: 4454453
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G; Fabbri F; Benvenuti C
    Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arterial occlusive disease: reducing blood viscosity through drugs].
    Gnauen H
    Med Klin; 1981 Feb; 76(5):144-6. PubMed ID: 7219342
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
    Guerrini M; Pecchi S; Rossi C; Cappelli R; Pieragalli D; Acciavatti A
    Ric Clin Lab; 1981; 11 Suppl 1():265-79. PubMed ID: 7188114
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drugs for the treatment of arterial circulation disorders].
    van der Kuy A
    Ned Tijdschr Geneeskd; 1988 Apr; 132(17):788. PubMed ID: 3374665
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic aspects in disorders of the microcirculation in peripheral arterial occlusive diseases].
    Ehrly AM
    Vasa; 1974; 3(3):312-8. PubMed ID: 4423612
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of the vasodilator isoxsuprine and blood viscosity].
    Fernández J; De Quirós B; Hess H; Marshall M
    Rev Clin Esp; 1977 Sep; 146(5):275-8. PubMed ID: 337418
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reduction of blood fibrinogen concentration by defibrase: possibilities and limits].
    Martin M; Engelken HJ; Tambert F
    Verh Dtsch Ges Inn Med; 1973; 79():1336-8. PubMed ID: 4799539
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemorrheologic aspects in relation to the physiopathology and clinical aspects of peripheral occlusive arteriopathy].
    Perego MA; Sergio G; Artale F
    Ric Clin Lab; 1981; 11 Suppl 1():281-91. PubMed ID: 7188115
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of isoxsuprine on blood viscosity].
    Schlichting K; Heidrich H
    Vasa; 1976; 5(1):51-3. PubMed ID: 973411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.